Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. [electronic resource]
Producer: 19990416Description: 625-36 p. digitalISSN:- 0003-4819
- Aged
- Anti-Arrhythmia Agents -- adverse effects
- Anticoagulants -- adverse effects
- Aspirin -- adverse effects
- Atrial Fibrillation -- therapy
- Cerebrovascular Disorders -- etiology
- Combined Modality Therapy
- Cost-Benefit Analysis
- Decision Support Techniques
- Electric Countershock -- economics
- Female
- Humans
- Male
- Markov Chains
- Platelet Aggregation Inhibitors -- adverse effects
- Quality-Adjusted Life Years
- Recurrence
- Risk Factors
- Warfarin -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.